• Profile
Close

Effect of on-demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in Intensive Care Unit patients receiving invasive ventilation: A randomized clinical trial

JAMA Mar 22, 2018

van Meenen DMP, et al. - The researchers sought to assess if a strategy that uses nebulization for clinical indication (on-demand) is noninferior to one that uses preventive (routine) nebulization among Intensive Care Unit (ICU) patients receiving invasive ventilation. On-demand compared with routine nebulization of acetylcysteine with salbutamol did not lead to an inferior number of ventilator-free days among the ICU patients who were expected to not be extubated within 24 hours. Findings suggested on-demand nebulization to be a reasonable alternative to routine nebulization.

Methods

  • Researchers performed randomized clinical trial enrolling adult patients expected to need invasive ventilation for more than 24 hours at 7 ICUs in the Netherlands.
  • Interventions in this study included on-demand nebulization of acetylcysteine or salbutamol (based on strict clinical indications, n = 471) or routine nebulization of acetylcysteine with salbutamol (every 6 hours until end of invasive ventilation, n = 473).
  • The number of ventilator-free days at day 28, with a noninferiority margin for a difference between groups of -0.5 days was assessed as the primary outcome.
  • Length of stay, mortality rates, occurrence of pulmonary complications, and adverse events were included as secondary outcome measures.

Results

  • Researchers enrolled 922 patients (34% women; median age, 66 (interquartile range [IQR], 54-75 years); all of these patients completed follow-up.
  • Patients in the on-demand group had a median 21 (IQR, 0-26) ventilator-free days, and patients in the routine group had a median 20 (IQR, 0-26) ventilator-free days at 28 days (1-sided 95% CI, -0.00003 to ∞).
  • No significant difference was observed in length of stay or mortality, or in the proportion of patients developing pulmonary complications, between the 2 groups.
  • With routine nebulization, more frequent adverse events were reported(13.8% vs 29.3%; difference, -15.5% [95% CI, -20.7% to -10.3%]; P < .001); these were mainly related to tachyarrhythmia (12.5% vs 25.9%; difference, -13.4% [95% CI, -18.4% to -8.4%]; P < .001) and agitation (0.2% vs 4.3%; difference, -4.1% [95% CI, -5.9% to -2.2%]; P < .001).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay